BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that management will be hosting investor meetings at the Guggenheim Securities 5th Annual Boston Healthcare Conference on Wednesday, December 13, 2017 at READ MORE


Comments

There are no comments

Antiprotozoal Sesquiterpene Lactones and Other Constituents from Tarchonanthus camphoratus and Schkuhria pinnata

Antiprotozoal Sesquiterpene Lactones and Other


POTD: Immature green with satellite tag in Saint-Martin, French West Indies myd.as/p7742

POTD: Immature green with satellite tag in


Discovery of Intermetallic Compounds from Traditional to Machine-Learning Approaches

Discovery of Intermetallic Compounds from


CELEBRATE AZ WATER: PLAN A DAY AT THE LAKE WITH SRP’S WATERSHED CONNECTION WEBSITE

CELEBRATE AZ WATER: PLAN A DAY AT THE LAKE WITH





Trending News